RecruitingNCT07686263
Official study titleA Phase 3 Double-blind, Placebo-controlled Randomized Withdrawal Maintenance Trial of KarXT Treatment in Participants With Schizophrenia
Multiple locations, including BentonvilleSchizophreniaMedication studyAges 18–65
- Countries
- United States, Argentina, Bulgaria, + 4 others
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
RecruitingNCT07518056
Official study titleAn Investigation of the Relationships Between Nomophobia Levels and Stress, Body Image and Food Addiction Among University Students
In IstanbulAddictionObservational studyAges 18–30
- Countries
- Türkiye
- Sponsor
- Bahçeşehir University